Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implantation of CERENOVUS ENTERPRISE 2 Intracranial Stent in Patients With Severe Symptomatic Intracranial Atherosclerotic Stenosis: A Multicenter, Prospective and Single-Arm Study in China

NCT05316311 is registered in ClinicalTrials.gov with Medos International SARL as lead sponsor.

NCT NCT05316311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05316311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implantation of CERENOVUS ENTERPRISE 2 Intracranial Stent in Patients With Severe Symptomatic Intracranial Atherosclerotic Stenosis: A Multicenter, Prospective and Single-Arm Study in China
Lead sponsor
Medos International SARL
Phase
Not applicable
Overall status
Completed
Start date
May 24, 2022
Completion date
December 24, 2025
Enrollment
194 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

intracranial atherosclerosis